Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-003159
Filing Date
2017-01-27
Accepted
2017-01-27 13:54:01
Documents
1
Period of Report
2017-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4207
  Complete submission text file 0001140361-17-003159.txt   5634
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRATI THERAPEUTICS INC. 4660 LA JOLLA VILLAGE DRIVE, SUITE 500 SAN DIEGO CA 92121
Business Address
HUMPHREY RACHEL (Reporting) CIK: 0001579781 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 17553051